September 18, 2017 — Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU ...
September 18, 2017 – Claret Medical announced publication of a new study in the Journal of the American College of ...
September 15, 2017 — Philips highlighted its newest solution for nuclear cardiology, CardioMD IV, at the American ...
September 14, 2017 — Marijuana use is associated with a three-fold risk of death from hypertension, according to ...
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials ...
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Sidra ...
September 13, 2017 — Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference ...
September 13, 2017 — A subset analysis of the DETOUR I clinical trial showed promising safety and effectiveness results ...
September 12, 2017 — A new screening program for vascular disease saves one life for every 169 men assessed, according ...
September 12, 2017 — Inclisiran lowers low-density lipoprotein (LDL, or “bad”) cholesterol for up to one year in ...
September 12, 2017 — Very aggressive reduction of LDL-cholesterol to ultra-low levels was associated with progressively ...
September 12, 2017 — The IL-1β inhibitor canakinumab lowers the risk of cardiovascular disease and lung cancer risk by ...
September 12, 2017 — Rivaroxaban plus aspirin improves survival and reduces stroke and heart attack in patients with ...
September 12, 2017 – The Cardiovascular Research Foundation (CRF) announced the promotion of Juan F. Granada, M.D., as ...